Integral Health Asset Management, LLC Chimerix Inc Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$1.34 - $5.34 $159,460 - $635,460	-119,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.58 - $6.8 $41,220 - $61,200	9,000 Added 8.18%	119,000 $545,000
Q4 2021 Feb 02, 2022	BUY	$5.23 - $7.18 $104,600 - $143,600	20,000 Added 22.22%	110,000 $707,000
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $89,100 - $131,250	15,000 Added 20.0%	90,000 $557,000
Q2 2021 Aug 30, 2021	SELL	$7.54 - $9.79 $565,500 - $734,249	-75,000 Reduced 50.0%	75,000 $600,000
Q2 2021 Aug 13, 2021	BUY	$7.54 - $9.79 $1.13 Million - $1.47 Million	150,000 New	150,000 $1.2 Million

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.